	Multicenter Study Suggests Unsupervised Learning Derived From MRI Identifies Prognostic Subgroups in Prostate Cancer Patients After Prostatectomy. Radiol Res Pract Hu G, Liu X, Chen Z, Zhou B, Gan H, Chen R, Zhou L, Gu Y, Liu X. PMID: 42283020 [PubMed]
	CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Hum Mutat Jiang Z, Ma P, Zhang S, Jin Z, Wang Y, Zhou Y, Zhu Q, Lu C, Tu N, Zhang ZA, Mou Y, Jin W. PMID: 42282992 [PubMed - in process]
	Usability of a novel cholangiopancreatoscope for tumor detection and stone management. VideoGIE Mitsuhashi S, Guralwar C, Khan R, Han S, AbiMansour JP, Vargas EJ, Petersen BT, Chandrasekhara V. PMID: 42282887 [PubMed]
	A Nomogram Integrating HOXA9 Expression and Clinicopathological Factors for Predicting Postoperative Recurrence in Gastric Cancer: A Single-Center Retrospective Study. Onco Targets Ther Weng J, Ying J, Xia M, Xie Y. PMID: 42282859 [PubMed]
	Medical imaging-derived artificial intelligence for prognostic stratification and treatment response prediction in interventional therapy of hepatocellular carcinoma. ILIVER Lei Y, Xia T, Wang Y, Zhou X, Gao X, Ju S. PMID: 42282465 [PubMed]
	Clinical and inflammatory biomarkers predicting emergency surgical management decisions and postoperative outcomes in complicated colon cancer. J Med Life Silaghi AM, Serban D, Pantu H, Motofei I, Shevchenko I, Atasiei DI, Iacoban SR, Voinea SC, Grigorescu CC, Constantin VD. PMID: 42282231 [PubMed - in process]
	Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis. J Natl Cancer Cent Yu J, Zhou Q, Wang G, Shi S, Wang H, Yang J, Sun X, Li J, Shi Y, Wang J, Guo X, Zou Y, Xie Y, Zhang Z, Zhang Y, Cai S, Hao J. PMID: 42282129 [PubMed]
	MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort. J Natl Cancer Cent Quan L, Chen S, Yang Z, Ju J, Lei Z, Huang Y, Qiao G, Yue J, He P, Yang J, Yuan P. PMID: 42282128 [PubMed]
	Extracellular vesicles in prostate cancer: current understanding and future perspectives. J Natl Cancer Cent Perumalsamy B, Seshacharyulu P, Vengoji R, Shonka N, Teply BA, Batra SK, Muniyan S. PMID: 42282127 [PubMed]
	Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis. J Natl Cancer Cent Gan Y, Tian R, Han S, Zeng H, Sun F. PMID: 42282126 [PubMed]
	Construction and external validation of radiomics models to detect primary prostate cancer with machine learning: a multicenter study based on (68)Ga-PSMA PET/CT. J Natl Cancer Cent Chen J, Jiang X, Yang G, Tang Y, Qi L, Chen M, Hu S, Gao X, Gan Y, Zhang M, Chen S, Cai Y. PMID: 42282124 [PubMed]
	Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study. J Natl Cancer Cent Zheng Y, Tan N, Teng Y, Li T, Wang J, Wu Y, Li Q, Cao M, He S, Zuo T, Xia C, Chen W. PMID: 42282122 [PubMed]
	Intrinsic and extrinsic regulators of cancer dormancy and awakening. J Natl Cancer Cent Zhang J, Khalil MI, Mishra R, Li H, Perelli L, Weinberg RA. PMID: 42282121 [PubMed]
	Enhancing cisplatin chemosensitivity in gastric cancer through LINC00162 silencing: Modulation of the PI3K/AKT pathway and NANOG downregulation. Bioimpacts Hosseini SA, Mokhtarzadeh AA, Ghorbian S, Baradaran B, Ahmadizadeh C. PMID: 42282112 [PubMed]
	Long non-coding RNA PURPL in cancer and cellular regulation: Mechanistic insights and therapeutic potential. Bioimpacts Valatabar N, Safaralizadeh R, Mokhtarzadeh AA, Hosseinpour Feizi MA. PMID: 42282110 [PubMed]
	Checkpoint inhibitors in microsatellite instability-high metastatic colorectal cancer: treatment strategies, specificities, and care management questions. ESMO Gastrointest Oncol André T, Lonardi S, Zaanan A, Cohen R, Taieb J. PMID: 42282106 [PubMed]
	Functional and behavioral outcomes in pediatric adrenal carcinoma under mitotane therapy: a caregiver-reported pilot study. Endocr Oncol Frey H, Riedmeier M, Krüger J, Classen CF, Domínguez-Pinilla N, Fragoso M, Fuchs S, Janus D, Mezoued M, Mocna A, Munarin J, Puglisi S, Susam Sen H, Tuli G, Walenciak J, Yalcin B, Fassnacht M, Wiegering V. PMID: 42281905 [PubMed]
	Multifaceted role of histopathology in liver transplantation for hepatocellular carcinoma: A narrative review towards precision prognosis. World J Transplant Amante MF, Vargas Wille MF, Pestalardo ML. PMID: 42281878 [PubMed]
	Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm. World J Transplant Arafat AMA, Soliman SMA, Elfandy H, Othman MO, Elsayed W, Lotfy MM, Ebrahim NAA. PMID: 42281857 [PubMed]
	Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study. Res Rep Urol Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42281847 [PubMed]

Articles 1 - 20 / 1942821

Page 1 of 97142



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy